Regul Pept 2006,133(1–3):115–122.PubMedCrossRef 8. Martinez A, Vos M, Guedez L, Kaur G, Chen Z, Garayoa M, Pio R, Moody T, Stetler-Stevenson
WG, Kleinman HK, et al.: The effects of adrenomedullin overexpression in breast tumor cells. J Natl Cancer Inst 2002,94(16):1226–1237.PubMedCrossRef www.selleckchem.com/products/elacridar-gf120918.html 9. Hata K, Takebayashi Y, Akiba S, Fujiwaki R, Iida K, Nakayama K, Nakayama S, Fukumoto M, Miyazaki K: Expression of the adrenomedullin gene in epithelial ovarian cancer. Mol Hum Reprod 2000,6(10):867–872.PubMedCrossRef 10. Miller MJ, Martinez A, Unsworth EJ, Thiele CJ, Moody TW, Elsasser T, Cuttitta F: Adrenomedullin expression in human tumor cell lines. Its potential role as an autocrine growth factor. J Biol Chem 1996,271(38):23345–23351.PubMedCrossRef 11. Giacalone PL, Vuaroqueaux V, Daures JP, Houafic L, Martin PM, Laffargue F, Maudelonde T: Expression of adrenomedullin in human ovaries, ovarian cysts and cancers – Correlation with estrogens receptor status. Eur J Obstet Gynecol Reprod Biol 2003,110(2):224–229.PubMedCrossRef
12. Zhang Y, Zhang S, www.selleckchem.com/products/GDC-0449.html Shang H, Pang X, Zhao Y: Basic fibroblast growth factor upregulates adrenomedullin expression in ovarian epithelial carcinoma cells via JNK-AP-1 pathway. Regul Pept 2009,157(1–3):44–50.PubMedCrossRef 13. Springer TA, Wang JH: The three-dimensional structure of integrins and their ligands, and conformational regulation of cell adhesion. Cell Surface Receptors 2004, 68:29.CrossRef 14. Buczek-Thomas JA, Chen N, Hasan T: Integrin-mediated adhesion and signalling in ovarian cancer cells. Cell Signal 1998,10(1):55–63.PubMedCrossRef 15. Reuning U: Integrin alpha v beta 3 Promotes Vitronectin Gene Expression in Human Ovarian Cancer Cells by Implicating Rel Transcription PCI-32765 in vivo Factors. J Cell Biochem 2011,112(7):1909–1919.PubMedCrossRef 16. Sawada K, Mitra AK, Radjabi
AR, Bhaskar V, Kistner EO, Tretiakova M, Jagadeeswaran S, Montag A, Becker A, Kenny HA, et al.: Loss of E-cadherin promotes ovarian cancer metastasis via alpha(5)-integrin, which is a therapeutic target. Cancer Res 2008,68(7):2329–2339.PubMedCrossRef 17. Mitra AK, Sawada K, Tiwari P, Mui K, Gwin K, Lengyel E: Ligand-independent GNE-0877 activation of c-Met by fibronectin and alpha(5)beta(1)-integrin regulates ovarian cancer invasion and metastasis. Oncogene 2011,30(13):1566–1576.PubMedCrossRef 18. Morozevich G, Kozlova N, Cheglakov I, Ushakova N, Berman A: Integrin alpha 5 beta 1 controls invasion of human breast carcinoma cells by direct and indirect modulation of MMP-2 collagenase activity. Cell Cycle 2009,8(14):2219–2225.PubMedCrossRef 19. Ramakrishnan V, Bhaskar V, Law DA, Wong MHL, DuBridge RB, Breinberg D, O’Hara C, Powers DB, Liu G, Grove J, et al.: Preclinical evaluation of an anti-alpha5beta1 integrin antibody as a novel anti-angiogenic agent. J Exp Ther Oncol 2006,5(4):273–286.PubMed 20.